Related Experiment Video
Updated: Jun 16, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Ongoing pain despite aggressive opioid pain management among persons with HIV
John Koeppe1, Carl Armon, Karen Lyda
1Division of Infectious Diseases, Departments of Medicine, University of Colorado Denver, Aurora, CO 80045, USA. john.koeppe@uchsc.edu
Insights
Opioid use for chronic pain in people with HIV is linked to psychosocial factors and a history of AIDS. Patients on opioids still report higher pain levels, indicating limited efficacy.
Area of Science:
- Pain Management
- Infectious Diseases
- Public Health
Background:
- Chronic pain is prevalent in individuals with Human Immunodeficiency Virus (HIV).
- Opioids are commonly prescribed for managing chronic pain in this population.
- Limited data exist on factors influencing opioid use and its effectiveness in HIV patients.
Purpose of the Study:
- To investigate variables associated with opioid use for chronic pain in persons with HIV.
- To assess the efficacy of opioid therapy in managing chronic pain among HIV-positive individuals.
Main Methods:
- A cross-sectional cohort study was conducted in 2005.
- Patients were categorized into three groups: daily opioid therapy for chronic pain, chronic pain without daily opioids, and no chronic pain diagnosis.
- Self-reported pain data were collected and analyzed.
Main Results:
- Opioid users were more likely to use benzodiazepines/gamma-aminobutyric receptor agonists, have a history of injection drug use, lack private insurance, report abuse, have a history of AIDS, and attend appointments more frequently.
- Patients on opioid therapy reported significantly higher pain scores (4.3 vs. 1.9 vs. 0.7) and greater pain severity (58.6% vs. 15.5% vs. 4.9%).
Conclusions:
- Psychosocial factors and a history of AIDS are associated with opioid prescribing in HIV patients.
- Opioid therapy did not resolve pain, as patients on these medications continued to report higher pain levels.
Background:
Chronic pain is a common problem among persons living with HIV and opioids are frequently used in its treatment. However, data on the variables associated with opioids use and the efficacy of this practice are lacking.
Methods:
We performed a cross-sectional cohort study of self-reported pain during the year 2005 in our clinic. Patients were grouped into 3 cohorts: those receiving daily opioid therapy for chronic pain (cohort 1, n=115), those with a chronic pain diagnosis but not on daily opioid therapy (cohort 2, n=209), and those without a chronic pain diagnosis (cohort 3, n=796).
Results:
In multivariate analysis comparing cohorts 1 and 2, patients in cohort 1 were significantly more likely to be on a benzodiazepine or gamma-aminobutyric receptor agonist [odds ratio (OR)=15.2], have injection drug use as a HIV risk factor (OR=4.27), lack private insurance (OR=3.51), have been abused (OR=3.08), have a history of AIDS (OR=2.21), and be seen more frequently (OR=1.18). Patients in cohort 1 reported significantly more pain [mean pain scores (0 to 10): 4.3 cohort 1; 1.9 cohort 2; 0.7 cohort 3], and were more likely to have pain that was of moderate or greater severity (58.6% cohort 1; 15.5% cohort 2; 4.9% cohort 3).
Conclusions:
Psychosocial variables and a history of AIDS were associated with opioid use in our clinic. Persons on opioids continued to experience significantly more pain than other patients in our clinic.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Chronic Pancreatitis II: Collaborative Care
Assessment:
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

